Voyxact

Sibeprenlimab · Otsuka America Pharmaceutical, Inc.
PRESCRIPTION ONLY (USA)

Voyxact ingredients

Active ingredientStrength
Sibeprenlimab200 mg/mL

What Voyxact is used for

Voyxact is a specialist medicine. Its approved uses are listed on the official FDA label below.

Key facts

Brand
Voyxact
Generic name
Sibeprenlimab
Made by
Otsuka America Pharmaceutical, Inc.
Forms
Injection
Given
Subcutaneous
FDA approval
Biologic licence (BLA) BLA761434
On the US market since
2025

Official information

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Voyxact?

Voyxact (Sibeprenlimab) is a specialist medicine made by Otsuka America Pharmaceutical, Inc., approved by the US FDA.

What are the ingredients of Voyxact?

Voyxact contains Sibeprenlimab (200 mg/mL).

From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.

← All specialty medicines, USA

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.